Eli Lilly and Company LLY will report its fourth-quarter and full-year 2024 earnings on Feb. 6, before market open. The Zacks ...

These growth stocks come from two very different industries. Eli Lilly is riding the GLP-1 drug wave, but there is much more ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...

Scientists compared 175 different health outcomes between those who took GLP-1 drugs to those who took traditional diabetes medications such as Jardiance. “We saw skyrocketing utilization of GLP ...

Share on Pinterest GLP-1 drugs may improve brain and heart health but could cause problems for the kidneys and pancreas, according to a new study. FreshSplash/Getty Images Researchers report that ...

Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for exceptional importation and sale are called "designated drugs".

Copyright 2025 The Associated Press. All Rights Reserved. President Joe Biden speaks about prescription drug costs at the National Institutes of Health in Bethesda ...

They included popular blood thinners Xarelto and Eliquis and diabetes drugs Jardiance and Januvia.The savings from the new list prices for those drugs were expected to generate about $6 billion ...

They included popular blood thinners Xarelto and Eliquis and diabetes drugs Jardiance and Januvia. The savings from the new list prices for those drugs were expected to generate about $6 billion ...

Medicare announced Friday that it has selected 15 drugs, including the hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, as well as some blockbuster cancer ...

It’s estimated 5.3 million Medicare members use the 15 drugs selected today. They account for $41 billion, or 14% of part D spending, from Nov. 1, 2023, to Oct. 31, 2024. GLP-1 drug costs over ...